๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Bioavailability Study of Two Different Verapamil Formulations

โœ Scribed by C. Horne; G. Stenzhorn; H. Blume; H. Knauf; E. Mutschler

Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
437 KB
Volume
325
Category
Article
ISSN
0365-6233

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Comparative bioavailability study of two
Comparative bioavailability study of two tablet formulations of cimetidine
โœ R. R. Berardi; I. A. Cohen; M. L. Hyneck; G. F. Lockwood; U. A. Shukla; E. Sakma ๐Ÿ“‚ Article ๐Ÿ“… 1984 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 378 KB ๐Ÿ‘ 2 views

A two-way crossover bioavailability study of two commercial cimetidine formulations was performed on 24 healthy male volunteers. Drug was administered after an overnight fast and plasma samples were withdrawn periodically for 12 h. Urine was collected throughout the study period. Results indicated t

Comparative bioavailability of two oral
Comparative bioavailability of two oral formulations of ranitidine
โœ Francisco J. Flores-Murrieta; Alejandra Toledo; Miriam del Carmen Carrasco-Portu ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 79 KB ๐Ÿ‘ 2 views

The current requirement of the Mexican Authorities to demonstrate the interchangeability of ranitidine formulations is to establish that the dissolution profile of the drug shows similarity. In order to establish if this requirement is adequate, the bioavailability of two formulations that did not m

Relative bioavailability of two oral for
Relative bioavailability of two oral formulations of navelbine in cancer patients
โœ X. J. Zhou; X. R. Zhou-Pan; R. Favre; R. Rahmani ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 401 KB ๐Ÿ‘ 2 views

A study was carried out in 14 cancer patients to assess the relative bioavailability of two oral formulations of navelbine. A single 130 mg oral dose of the drug was given according to a randomized two-way crossover design as two capsules: one contained the drug in powder (formulation A, reference);